z-logo
Premium
Low bioavailability hinders drug discovery against COVID‐19, guided by in silico docking
Author(s) -
Dey Priyankar
Publication year - 2021
Publication title -
british journal of pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.432
H-Index - 211
eISSN - 1476-5381
pISSN - 0007-1188
DOI - 10.1111/bph.15325
Subject(s) - in silico , adme , drug discovery , docking (animal) , computational biology , phytochemical , pharmacology , drug , biology , chemistry , bioinformatics , biochemistry , medicine , nursing , gene

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom